[go: up one dir, main page]

RU2006138371A - METHOD FOR TREATING POSTOPERATIVE INTESTINAL PARESIS - Google Patents

METHOD FOR TREATING POSTOPERATIVE INTESTINAL PARESIS Download PDF

Info

Publication number
RU2006138371A
RU2006138371A RU2006138371/14A RU2006138371A RU2006138371A RU 2006138371 A RU2006138371 A RU 2006138371A RU 2006138371/14 A RU2006138371/14 A RU 2006138371/14A RU 2006138371 A RU2006138371 A RU 2006138371A RU 2006138371 A RU2006138371 A RU 2006138371A
Authority
RU
Russia
Prior art keywords
treating postoperative
postoperative intestinal
intestinal paresis
paresis
treating
Prior art date
Application number
RU2006138371/14A
Other languages
Russian (ru)
Other versions
RU2336079C2 (en
Inventor
Умарасхаб Загирович Загиров (RU)
Умарасхаб Загирович Загиров
Разин Мирзекеримович Рагимов (RU)
Разин Мирзекеримович Рагимов
Заурбег Магомедсаидович Магомедов (RU)
Заурбег Магомедсаидович Магомедов
Гаджимурад Магомедович Далгатов (RU)
Гаджимурад Магомедович Далгатов
Муслим Абдурашидович Салихов (RU)
Муслим Абдурашидович Салихов
Зарипат Шахбановна Манасова (RU)
Зарипат Шахбановна Манасова
Original Assignee
Государственное образовательное учреждение высшего профессионального образовани "Дагестанска государственна медицинска академи федерального агентства по здравоохранению и социальному развитию" (RU)
Государственное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия федерального агентства по здравоохранению и социальному развитию"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное образовательное учреждение высшего профессионального образовани "Дагестанска государственна медицинска академи федерального агентства по здравоохранению и социальному развитию" (RU), Государственное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия федерального агентства по здравоохранению и социальному развитию" filed Critical Государственное образовательное учреждение высшего профессионального образовани "Дагестанска государственна медицинска академи федерального агентства по здравоохранению и социальному развитию" (RU)
Priority to RU2006138371/14A priority Critical patent/RU2336079C2/en
Publication of RU2006138371A publication Critical patent/RU2006138371A/en
Application granted granted Critical
Publication of RU2336079C2 publication Critical patent/RU2336079C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (1)

Способ лечения послеоперационного пареза кишечника, заключающийся в блокаде брыжейки кишечника лекарственной смесью, отличающийся тем, что в состав смеси включены 100 мл 0,25%-ного раствора новокаина и 50 мл эмульсии перфторана.A method of treating postoperative intestinal paresis, which consists in blocking the intestinal mesentery with a drug mixture, characterized in that the mixture contains 100 ml of a 0.25% solution of novocaine and 50 ml of perftoran emulsion.
RU2006138371/14A 2006-10-30 2006-10-30 Method of postoperative enteroparesis treatment RU2336079C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2006138371/14A RU2336079C2 (en) 2006-10-30 2006-10-30 Method of postoperative enteroparesis treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2006138371/14A RU2336079C2 (en) 2006-10-30 2006-10-30 Method of postoperative enteroparesis treatment

Publications (2)

Publication Number Publication Date
RU2006138371A true RU2006138371A (en) 2008-05-10
RU2336079C2 RU2336079C2 (en) 2008-10-20

Family

ID=39799603

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006138371/14A RU2336079C2 (en) 2006-10-30 2006-10-30 Method of postoperative enteroparesis treatment

Country Status (1)

Country Link
RU (1) RU2336079C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2445130C2 (en) * 2009-05-04 2012-03-20 Государственное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия федерального агентства по здравоохранению и социальному развитию" Method for prevention of postoperative enteroparesis
RU2405579C1 (en) * 2009-07-22 2010-12-10 Учреждение Российской академии медицинских наук Научно-исследовательский институт клинической и экспериментальной лимфологии Сибирского отделения РАМН Method of intestinal distention preventing in patients with widespread peritonitis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2203043C1 (en) * 2001-10-22 2003-04-27 2 Городская клиническая больница г. Ижевска Method of treatment of reversible ischemia of inter-intestine anasthomosis in peritonitis
RU2254890C1 (en) * 2004-02-16 2005-06-27 Северо-Осетинская Государственная академия медицинских наук Method for stimulating motor intestinal activity in patients with vertebral traumas

Also Published As

Publication number Publication date
RU2336079C2 (en) 2008-10-20

Similar Documents

Publication Publication Date Title
CY1120022T1 (en) Pediatric Acute Acute Lymphoblastic Leukemia Treatment
BRPI0810246A2 (en) Dpp-iv inhibitors including the beta-amino group, method of preparation thereof and pharmaceutical composition containing the same for the prevention and treatment of diabetes or obesity.
LT2878297T (en) MEDICINES FOR THE TREATMENT OR PREVENTION OF FIBROSIC DISEASES
ATE532518T1 (en) DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OF DIABETES
BRPI0916576A2 (en) at least one chemical entity, pharmaceutical composition, and method for treating a condition or disorder.
EA200900959A1 (en) MEK INHIBITORS
EP2021352A4 (en) TREATMENT OF PROTEIN MISCONDUCT
EA200800356A1 (en) TREATING CHOLESTEROL ABSORPTION WITH AZETIDINONE AND OMEGA-3 INHIBITOR WITH FATTY ACIDS AND THEIR COMBINED DRUG
CL2007003341A1 (en) COMPOUNDS DERIVED FROM IMIDAZOTRIAZINAS; PHARMACEUTICAL COMPOSITION, USEFUL FOR THE TREATMENT OF CANCER, ARTEROSCLEROSIS AND CARDIOVASCULAR DISEASES BETWEEN OTHERS.
EA200802184A1 (en) PHARMACEUTICAL COMPOSITIONS WITH DPP IV INHIBITORS
BRPI0814957A2 (en) COMPOUND, PRODUCT, PHARMACEUTICAL AGENT, METHOD FOR PROPHYLAXY OR TREATMENT OF A DISEASE, DISORDER OR CONDITION, AND USE OF THE COMPOUND.
BRPI0813311A2 (en) COMPOUND, METHODS FOR MODULATING THE ACTIVITY OF A PROTEIN KINASE AND FOR TREATING CANCER IN AN INDIVIDUAL AND PHARMACEUTICAL COMPOSITION.
BRPI0909768A2 (en) compound, pharmaceutical composition, method for treating or preventing a disease or disorder mediated by activation of b3-adrenoceptor, and use of a compound, pharmaceutical composition, method for treating or preventing a disease or disorder mediated by b3-adrenoceptor. b3-adrenoceptor activation, and use of a compound
WO2008144061A3 (en) Novel combinations comprising a phosphodiesterase-5 inhibitor and their use
BRPI0915382A2 (en) compound, pharmaceutical composition, and method for treating a disease or disorder.
BRPI0815591A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, USE OF A COMPOUND, AND METHOD FOR TREATING A DISEASE, CONDITION OR DISTURBANCE.
BRPI0912539A2 (en) compound, pharmaceutical composition, method for treating a disease, and use of the compound.
BRPI0510142A (en) compounds, compositions and methods for stabilizing transthyretin and inhibiting defective duplication of transthyretin
DE602005019282D1 (en) SUBSTITUTED ARYL ACYLTYL DRUGS AND RELATED COMPOUNDS, VIRUS REPLICATION INHIBITORS
BRPI0813402A2 (en) AGENT TO AVOID OR TREAT A CANCER RESISTANT CANCER, TRUGUZUMAB, COMBINED DRUG, METHODS TO PREVENT OR TREAT CANCER RESISTANT CANCER TO EXAMINE A SENSITIVITY OF A CANCER EXPRESSING HER2 TO A JERUSAL CANCER JUMPER, TO A HER2 INHIBITOR AND TO TAKE A DRUG FOR PROPHYLAXY OR TREATMENT OF A CANCER RESISTANT TO TRASTUZUMAB, AND, USE OF ONE OR MORE DRUGS.
BR112012003462A2 (en) "compound, pharmaceutical composition, and method for treating a patient having a protein kinase mediated condition."
GT200900065A (en) DERIVED FROM 2-PYRIDINCARBOXAMIDE THAT HAS GK ACTIVATING EFFECT
LTC2805723I2 (en) CLADRIBIN REGIME FOR THE TREATMENT OF MULTIPLE SCLEROSIS
BRPI0718469A2 (en) USE OF AN INTERLEUCIN 1 ANTAGONIST (IL-1), METHOD FOR TREATING, INHIBITING OR IMPROVING PSEUDOGOTA, USE OF ONE OR MORE THERAPEUTIC AGENTS, AND, PRODUCT.
BRPI0923856A2 (en) compound, pharmaceutical composition, use of a compound, and method for treating a disease or disorder.

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20081031